Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Background and aims: People with type 2 diabetes mellitus (T2DM) have a greater risk of cardiovascular (CV) disease and major adverse CV events (MACE) that is more common as renal function declines
Key Benefits: Skin Lightening & Brightening: Visibly reduces dark spots, pigmentation, and dullness for a more luminous complexion
Regulation of growth factor pathways involved in tissue repair
FOXO6, the last family member to be discovered, is the least characterized isoform which makes it difficult to compare its expression with the others
November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment
reveals a lack of evidence for probiotics as a treatment for gastrointestinal symptoms in ME/CFS patients, largely due to poor study quality [85]
US$ 28.89
US$ 27.00
US$ 27.55
US$ 28.94
US$ 26.34
